{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:37:12Z","timestamp":1787798232488,"version":"build-2784847793"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"YOK","award":["100\/2000"],"award-info":[{"award-number":["100\/2000"]}]},{"DOI":"10.13039\/501100004410","name":"TUBITAK","doi-asserted-by":"crossref","award":["BIDEB"],"award-info":[{"award-number":["BIDEB"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["315S302"],"award-info":[{"award-number":["315S302"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05505-0","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:54:25Z","timestamp":1765961665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systematic Characterization of LUHMES Cell-Based Parkinson\u2019s Disease Models Reveals Potential Novel Drug Targets"],"prefix":"10.1007","volume":"63","author":[{"given":"Esra Nur","family":"Yi\u011fit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekin","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regan","family":"Odongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zgenur","family":"Akda\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eeyma","family":"\u00c7imen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcrkan","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunahan","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-4763","authenticated-orcid":false,"given":"I\u015f\u0131l Aksan","family":"Kurnaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"1","key":"5505_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3(1):17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"issue":"10291","key":"5505_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303","journal-title":"Lancet"},{"key":"5505_CR3","doi-asserted-by":"publisher","first-page":"863921","DOI":"10.3389\/fsurg.2022.863921","volume":"9","author":"SN Serva","year":"2022","unstructured":"Serva SN, Bernstein J, Thompson JA, Kem DS, Ojemann SG (2022) An update on advanced therapies for Parkinson\u2019s disease: from gene therapy to neuromodulation. Front Surg 9:863921","journal-title":"Front Surg"},{"key":"5505_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s42269-023-01047-4","volume":"47","author":"A Sayyaed","year":"2023","unstructured":"Sayyaed A, Saraswat N, Vyawahare N, Kulkarni A (2023) A detailed review of pathophysiology, epidemiology, cellular and molecular pathways involved in the development and prognosis of Parkinson\u2019s disease with insights into screening models. Bull Nat Res Cent 47:70","journal-title":"Bull Nat Res Cent"},{"issue":"3","key":"5505_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1039\/D2MO00267A","volume":"19","author":"EN Yigit","year":"2023","unstructured":"Yigit EN, Sonmez E, Yuksel I, Aksan Kurnaz I, Cakir T (2023) A transcriptome based approach to predict candidate drug targets and drugs for Parkinson\u2019s disease using an in vitro 6-OHDA model. Mol Omics 19(3):218\u2013228","journal-title":"Mol Omics"},{"key":"5505_CR6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/aps.2014.36","volume":"35","author":"X Zhang","year":"2014","unstructured":"Zhang X, Yin M, Zhang M (2014) Cell-based assays for Parkinson\u2019s disease using differentiated human LUHMES cells. Acta Pharm Sin 35:945\u2013956","journal-title":"Acta Pharm Sin"},{"key":"5505_CR7","volume":"1866","author":"DS Harischandra","year":"2020","unstructured":"Harischandra DS, Rokad D, Ghaisas S, Verma S, Robertson A, Jin H, Anantharam V, Kanthasamy A et al (2020) Enhanced differentiation of human dopaminergic neuronal cell model for preclinical translational research in Parkinson\u2019s disease. BBA Mol Cell Res 1866:165533","journal-title":"BBA Mol Cell Res"},{"key":"5505_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3389\/fnins.2015.00503","volume":"9","author":"SA Jagmag","year":"2016","unstructured":"Jagmag SA, Tripathi N, Shukla SD, Maiti S, Khurana S (2016) Evaluation of models of Parkinson\u2019s disease. Front Neurosci 9:503. https:\/\/doi.org\/10.3389\/fnins.2015.00503","journal-title":"Front Neurosci"},{"issue":"5","key":"5505_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/j.1471-4159.2011.07255.x","volume":"119","author":"D Scholz","year":"2011","unstructured":"Scholz D, Poeltl D, Genewsky A, Weng M, Waldmann T, Schildknecht S, Leist M (2011) Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J Neurochem 119(5):957\u2013971","journal-title":"J Neurochem"},{"issue":"4","key":"5505_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.14573\/altex.2013.4.427","volume":"30","author":"S Schildknecht","year":"2013","unstructured":"Schildknecht S, Karreman C, Poeltl D, Efremova L, Kullmann C, Gutbier S, Krug A, Scholz D et al (2013) Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases. Altex 30(4):427\u2013444","journal-title":"Altex"},{"key":"5505_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.787059","volume":"13","author":"M Hoellerhage","year":"2022","unstructured":"Hoellerhage M, Stepath M, Kohl M, Pfeiffer K, Wing ho Chua O, Duan L, Hopfner F, Eisenacher M et al (2022) Transcriptome and proteome analysis in LUHMES cells overexpressing alpha-synuclein. Front Neurol 13:787059","journal-title":"Front Neurol"},{"key":"5505_CR12","doi-asserted-by":"publisher","first-page":"2000174","DOI":"10.1002\/pmic.202000174","volume":"21","author":"J Tueshaus","year":"2021","unstructured":"Tueshaus J, Kataka ES, Zaucha J, Frishman D, Mueller SA, Lichtenthaler SF (2021) Neuronal differentiation of LUHMES cells induces substantial changes of the proteome. Proteomics 21:2000174","journal-title":"Proteomics"},{"key":"5505_CR13","doi-asserted-by":"publisher","first-page":"13122","DOI":"10.3390\/ijms252313122","volume":"25","author":"CN Keighron","year":"2024","unstructured":"Keighron CN, Avazzedeh S, Quinlan LR (2024) Robust in vitro models for studying Parkinson\u2019s disease? LUHMES cells and SH-SY5Y cells. Int J Mol Sci 25:13122","journal-title":"Int J Mol Sci"},{"key":"5505_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00702-022-02479-4","volume":"129","author":"RM Kostrzewa","year":"2022","unstructured":"Kostrzewa RM (2022) Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson\u2019s disease. J Neural Transm 129:445\u2013446","journal-title":"J Neural Transm"},{"key":"5505_CR15","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114\u20132120","journal-title":"Bioinformatics"},{"key":"5505_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray NL, Pimentel H, Melsted P, Pachter L (2016) Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol 34:525\u2013527","journal-title":"Nat Biotechnol"},{"key":"5505_CR17","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.2","volume":"4","author":"C Soneson","year":"2016","unstructured":"Soneson C, Love MI, Robinson MD (2016) Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4:1521","journal-title":"F1000Res"},{"key":"5505_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W Huber","year":"2015","unstructured":"Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS et al (2015) Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods 12:115\u2013121","journal-title":"Nat Methods"},{"key":"5505_CR19","doi-asserted-by":"crossref","unstructured":"Clough E, Barrett T (2016) The gene expression omnibus database. Methods Mol Biol Clifton NJ 1418:93\u2013110","DOI":"10.1007\/978-1-4939-3578-9_5"},{"key":"5505_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s12640-020-00272-3","volume":"38","author":"ZB Tong","year":"2020","unstructured":"Tong ZB, Braisted J, Chu P-H, Gerhold D (2020) The MT1G gene in LUHMES neurons is a sensitive biomarker of neurotoxicity. Neurotox Res 38:967\u2013978","journal-title":"Neurotox Res"},{"key":"5505_CR21","doi-asserted-by":"publisher","first-page":"eadh3347","DOI":"10.1126\/sciadv.adh3347","volume":"9","author":"W Peng","year":"2023","unstructured":"Peng W, Schr\u00f6der LF, Song P, Wong YC, Krainc D (2023) Parkin regulates amino acid homeostasis at mitochondria-lysosome (M\/L) contact sites in Parkinson\u2019s disease. Sci Adv 9:eadh3347","journal-title":"Sci Adv"},{"key":"5505_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2022.100452","volume":"22","author":"Y Jang","year":"2023","unstructured":"Jang Y, Pletnikova O, Troncoso JC, Pantelyat AY, Dawson TM, Rosenthal LS, Na CH (2023) Mass spectrometry\u2013based proteomics analysis of human substantia nigra from Parkinson\u2019s disease patients identifies multiple pathways potentially involved in the disease. Mol Cell Proteomics 22:100452","journal-title":"Mol Cell Proteomics"},{"key":"5505_CR23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550","journal-title":"Genome Biol"},{"issue":"W1","key":"5505_CR24","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H, Vilo J (2019) G:profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res 47(W1):W191\u2013W198. https:\/\/doi.org\/10.1093\/nar\/gkz369","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"5505_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/15427951.2011.604548","volume":"7","author":"N Alcaraz","year":"2011","unstructured":"Alcaraz N, K\u00fcc\u00fck H, Weile J, Wipat A, Baumbach J (2011) KeyPathwayMiner: detecting case-specific biological pathways using expression data. Internet Math 7(4):299\u2013313. https:\/\/doi.org\/10.1080\/15427951.2011.604548","journal-title":"Internet Math"},{"issue":"1","key":"5505_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00441-017-2734-5","volume":"373","author":"E Glaab","year":"2018","unstructured":"Glaab E (2018) Computational systems biology approaches for Parkinson\u2019s disease. Cell Tissue Res 373(1):91\u2013109","journal-title":"Cell Tissue Res"},{"key":"5505_CR27","doi-asserted-by":"publisher","first-page":"108028","DOI":"10.1016\/j.compbiolchem.2024.108028","volume":"109","author":"E Duz","year":"2024","unstructured":"Duz E, Cakir T (2024) Effect of RNA-Seq data normalization on protein interactome mapping for Alzheimer\u2019s disease. Comp Biol Chem 109:108028","journal-title":"Comp Biol Chem"},{"key":"5505_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/pro.3978","volume":"30","author":"R Oughtred","year":"2021","unstructured":"Oughtred R, Rust J, Chang C, Breitkreutz BJ, Stark C, Willems A, Boucher L, Leung G et al (2021) The BioGRID database: a comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci Publ Protein Soc 30:187\u2013200","journal-title":"Protein Sci Publ Protein Soc"},{"key":"5505_CR29","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.12688\/f1000research.9054.1","volume":"5","author":"N Alcaraz","year":"2016","unstructured":"Alcaraz N, List M, Dissing-Hansen M, Rehmsmeier M, Tan Q, Mollenhauer J, Ditzel HJ, Baumbach J (2016) Robust de novo pathway enrichment with KeyPathwayMiner 5. F1000Res 5:1531","journal-title":"F1000Res"},{"key":"5505_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s11704-016-5485-7","volume":"10","author":"W Ju","year":"2016","unstructured":"Ju W, Li J, Yu W, Zhang R (2016) Igraph: an incremental data processing system for dynamic graph. Front Comput Sci 10:462\u2013476","journal-title":"Front Comput Sci"},{"key":"5505_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrg1272","volume":"5","author":"A-L Barab\u00e1si","year":"2004","unstructured":"Barab\u00e1si A-L, Oltvai ZN (2004) Network biology: understanding the cell\u2019s functional organization. Nat Rev Genet 5:101\u2013113","journal-title":"Nat Rev Genet"},{"key":"5505_CR32","doi-asserted-by":"publisher","first-page":"e1005771","DOI":"10.1371\/journal.pcbi.1005771","volume":"13","author":"T Ideker","year":"2017","unstructured":"Ideker T, Nussinov R (2017) Network approaches and applications in biology. PLoS Comput Biol 13:e1005771","journal-title":"PLoS Comput Biol"},{"key":"5505_CR33","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/proceedings2251559","volume":"2","author":"EN Yigit","year":"2018","unstructured":"Yigit EN, Sonmez E, Savasan Sogut M, Cakir T, Aksan Kurnaz I (2018) Validation of an in vitro Parkinson\u2019s disease model for the study of neuroprotection. Proceedings 2:1559. https:\/\/doi.org\/10.3390\/proceedings2251559","journal-title":"Proceedings"},{"key":"5505_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/wdev.260","author":"ET Arena","year":"2017","unstructured":"Arena ET, Rueden CT, Hiner MC, Wang S, Yuan M, Eliceiri KW (2017) Quantitating the cell: turning images into numbers with ImageJ. Wiley Interdiscip Rev Dev Biol. https:\/\/doi.org\/10.1002\/wdev.260","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"8","key":"5505_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","volume":"14","author":"B Dehay","year":"2015","unstructured":"Dehay B, Bourdenx M, Gorry P, Przedborski S, Vila M, Hunot S, Singleton A, Olanow CW et al (2015) Targeting \u03b1-synuclein for treatment of Parkinson\u2019s disease: mechanistic and therapeutic considerations. Lancet Neurol 14(8):855\u2013866. https:\/\/doi.org\/10.1016\/S1474-4422(15)00006-X","journal-title":"Lancet Neurol"},{"key":"5505_CR36","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/jamaneurol.2014.994","volume":"71","author":"E Kara","year":"2014","unstructured":"Kara E, Kiely AP, Proukakis C, Giffin N, Love S, Hehir J, Rantell K, Pandraud A et al (2014) A 6.4 Mb duplication of the \u03b1-synuclein locus causing frontotemporal dementia and Parkinsonism: phenotype-genotype correlations. JAMA Neurol 71:1162\u20131171","journal-title":"JAMA Neurol"},{"key":"5505_CR37","doi-asserted-by":"publisher","first-page":"D833","DOI":"10.1093\/nar\/gkw943","volume":"45","author":"J Pi\u00f1ero","year":"2017","unstructured":"Pi\u00f1ero J, Bravo A, Queralt-Rosinach N, Gutierrez-Sacristan A, Deu-Pons J, Centeno E, Garcia-Garcia J, Sanz F et al (2017) DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res 45:D833\u2013D839","journal-title":"Nucleic Acids Res"},{"key":"5505_CR38","doi-asserted-by":"publisher","unstructured":"Liharska LE, Park YJ, Ziafat K, Wilkins L, Silk H, Linares LM, Vornholt E, Sullivan B, Cohen V, Kota P et al (2023) A study of gene expression in the living human brain. 2023.04.21.23288916. Preprint at https:\/\/doi.org\/10.1101\/2023.04.21.23288916","DOI":"10.1101\/2023.04.21.23288916"},{"issue":"44","key":"5505_CR39","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1038\/s41388-021-02020-z","volume":"40","author":"D Moskovich","year":"2021","unstructured":"Moskovich D, Finkelshtein Y, Alfandari A, Rosemarin A, Lifschytz A, Mondal S, Ungati H, Katzav A et al (2021) Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. Oncogene 40(44):6248\u20136257","journal-title":"Oncogene"},{"issue":"7","key":"5505_CR40","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.bbadis.2016.05.014","volume":"1863","author":"WY Wani","year":"2017","unstructured":"Wani WY, Kandimalla RJL, Sharma DR, Kaushal A, Ruban A, Sunkaria A, Vallamkondu J, Chiarugi A et al (2017) Cell cycle activation in p21 dependent pathway: an alternative mechanism of organophosphate induced dopaminergic neurodegeneration. Biochim Biophys Acta Mol Basis Dis 1863(7):1858\u20131866","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"7","key":"5505_CR41","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/hipo.20003","volume":"14","author":"PF Fabene","year":"2004","unstructured":"Fabene PF, Andrioli A, Priel MR, Cavalheiro EA, Bentivoglio M (2004) Fos induction and persistence, neurodegeneration, and interneuron activation in the hippocampus of epilepsy-resistant versus epilepsy-prone rats after pilocarpine-induced seizures. Hippocampus 14(7):895\u2013907","journal-title":"Hippocampus"},{"key":"5505_CR42","doi-asserted-by":"publisher","unstructured":"Zhuang J, Miao C, Liu C, Zeng B, Hu L, Peng J, Xia Y, Chen Z (2024) Exploring the impact of ITGB2 on glioma progression and treatment: insights from non-apoptotic cell death and immunotherapy. Environ Toxicol. https:\/\/doi.org\/10.1002\/tox.24231","DOI":"10.1002\/tox.24231"},{"key":"5505_CR43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.freeradbiomed.2024.06.020","volume":"222","author":"Z Yao","year":"2024","unstructured":"Yao Z, Jia F, Wang S, Jiao Q, Du XX, Chen X, Jiang H (2024) The involvement of IRP2-induced ferroptosis through the p53-SLC7A11-ALOX12 pathway in Parkinson\u2019s disease. Free Radic Biol Med 222:386\u2013396","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"5505_CR44","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.neuro.2009.09.005","volume":"30","author":"J Wang","year":"2009","unstructured":"Wang J, Rahman MF, Duhart HM, Newport GD, Patterson TA, Murdock RC, Hussain SM, Schlager JJ et al (2009) Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver or copper nanoparticles. Neurotoxicol 30(6):926\u2013933","journal-title":"Neurotoxicol"},{"issue":"8","key":"5505_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082260","volume":"19","author":"M Nitti","year":"2018","unstructured":"Nitti M, Piras S, Brondolo L, Marinari UM, Pronzato MA, Furfaro AL (2018) Heme oxygenase 1 in the nervous system: does it favor neuronal cell survival or induce neurodegeneration? Int J Mol Sci 19(8):2260. https:\/\/doi.org\/10.3390\/ijms19082260","journal-title":"Int J Mol Sci"},{"key":"5505_CR46","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pneurobio.2018.06.008","volume":"172","author":"HM Schipper","year":"2019","unstructured":"Schipper HM, Song W, Tavitian A, Cressatti M (2019) The sinister face of heme oexygenase-1 in brain aging and disease. Prog Neurobiol 172:40\u201370","journal-title":"Prog Neurobiol"},{"issue":"2","key":"5505_CR47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1471-4159.2009.06160.x","volume":"110","author":"HM Schipper","year":"2009","unstructured":"Schipper HM, Song W, Zukor H, Hascalovici JR, Zeligman D (2009) Heme oexygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem 110(2):469\u2013485","journal-title":"J Neurochem"},{"issue":"8","key":"5505_CR48","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/antiox9080743","volume":"9","author":"DSA Simpson","year":"2020","unstructured":"Simpson DSA, Oliver PL (2020) ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease. Antiox 9(8):743","journal-title":"Antiox"},{"issue":"37","key":"5505_CR49","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.1523\/JNEUROSCI.0625-19.2019","volume":"39","author":"S Luo","year":"2019","unstructured":"Luo S, Kang SS, Wang ZH, Liu X, Day JX, Wu Z, Peng J, Xiang D et al (2019) Akt phosporylates NQO1 and triggers its degradation, abolishing its antioxidative activities in Parkinson\u2019s disease. J Neurosci 39(37):7291\u20137305","journal-title":"J Neurosci"},{"issue":"1","key":"5505_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12967-023-04802-3","volume":"22","author":"L Yuhan","year":"2024","unstructured":"Yuhan L, Khaleghi Ghadiri M, Gorji A (2024) Impact of NQO1 dysregulation in CNS disorders. J Transl Med 22(1):4","journal-title":"J Transl Med"},{"key":"5505_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neuint.2017.05.003","volume":"109","author":"C Kim","year":"2017","unstructured":"Kim C, Potluri P, Khalil A, Gaut D, McManus M, Compton S, Wallace DC, Yadava N (2017) An X-chromosome linked mouse model (Ndufa1S55A) for systemic partial complex I deficiency for studying predisposition to neurodegeneration and other diseases. Neurochem Int 109:78\u201393","journal-title":"Neurochem Int"},{"key":"5505_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neulet.2017.09.051","volume":"662","author":"P Kong","year":"2018","unstructured":"Kong P, Lei P, Zhang S, Li D, Zhao J, Zhang B (2018) Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson\u2019s disease. Neurosci Lett 662:51\u201358","journal-title":"Neurosci Lett"},{"issue":"8","key":"5505_CR53","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1093\/brain\/awab135","volume":"144","author":"HL Dong","year":"2021","unstructured":"Dong HL, Ma Y, Yu H, Wei Q, Li JQ, Liu GL, Li HF, Chen L et al (2021) Bi-allelic loss of function variants in COX20 gene cause autosomal recessive sensory neuropathy. Brain 144(8):2457\u20132470","journal-title":"Brain"},{"key":"5505_CR54","doi-asserted-by":"publisher","first-page":"854321","DOI":"10.3389\/fmolb.2022.854321","volume":"9","author":"B Ebanks","year":"2022","unstructured":"Ebanks B, Chakrabarti L (2022) Mitochondrial ATP synthase is a target of oxidative stress in neurodegenerative diseases. Front Mol Biosci 9:854321","journal-title":"Front Mol Biosci"},{"key":"5505_CR55","doi-asserted-by":"publisher","first-page":"113400","DOI":"10.1016\/j.expneurol.2020.113400","volume":"332","author":"N Mnatsakanyan","year":"2020","unstructured":"Mnatsakanyan N, Jonas EA (2020) The new role of F(1)F(0) ATP synthase in mitochondria-mediated neurodegeneration and neuroprotection. Exp Neurol 332:113400","journal-title":"Exp Neurol"},{"issue":"10","key":"5505_CR56","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.cell.2021.03.032","volume":"184","author":"MK Shin","year":"2021","unstructured":"Shin MK, Vazquez-Rosa E, Koh Y, Dhar M, Chaubey K, Cintron Perez CJ, Barker S, Miller E et al (2021) Reducing acetylated tau is neuroprotective in brain injury. Cell 184(10):2715\u20132732","journal-title":"Cell"},{"issue":"6","key":"5505_CR57","first-page":"e40463","volume":"15","author":"DI Razick","year":"2023","unstructured":"Razick DI, Akhtar M, Wen J, Alam M, Dean N, Karabala M, Ansari U, Ansari Z et al (2023) The role of sirtuin 1 (SIRT1) in neurodegeneration. Cureus 15(6):e40463","journal-title":"Cureus"},{"key":"5505_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00372","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhang Y, Zhu K, Chi S, Wang C, Xie A (2020) Emerging role of sirtuin 2 in Parkinson\u2019s disease. Front Aging Neurosci 11:372. https:\/\/doi.org\/10.3389\/fnagi.2019.00372","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"5505_CR59","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/cells11010090","volume":"11","author":"SS Santos","year":"2021","unstructured":"Santos SS, Moreira JB, Costa M, Ridrigues RS, Sebastiao AM, Xapelli S, Sola S (2021) The mitochondrial antioxidant sirtuin3 cooperates with lipid metabolism to safeguard neurogenesis in aging and depression. Cells 11(1):90","journal-title":"Cells"},{"issue":"1","key":"5505_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01334-2","volume":"15","author":"Q Wang","year":"2023","unstructured":"Wang Q, Wang Y, Li S, Shi J (2023) PACAP-sirtuin3 alleviates cognitive impairment through autophagy in Alzheimer\u2019s disease. Alzheimers Res Ther 15(1):184. https:\/\/doi.org\/10.1186\/s13195-023-01334-2","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"5505_CR61","doi-asserted-by":"publisher","first-page":"701","DOI":"10.7150\/ijbs.29323","volume":"15","author":"Y Fan","year":"2019","unstructured":"Fan Y, Yang Q, Gao Z, Zhang L, Liang W, Ding G (2019) Sirt6 suppresses high glucose-induced mitochondrial dysfunction and apoptosis in podocytes through AMPK activation. Int J Biol Sci 15(3):701\u2013713","journal-title":"Int J Biol Sci"},{"key":"5505_CR62","doi-asserted-by":"publisher","first-page":"7619255","DOI":"10.1155\/2022\/7619255","volume":"2022","author":"L Liu","year":"2022","unstructured":"Liu L, Bai J, Liu F, Zhao M, Zhao C, Zhao Z (2022) Cross-talking pathways of forkhead box O1 (FOXO1) are involved in the pathogenesis of Alzheimer\u2019s disease and Huntington\u2019s disease. Oxid Med Cell Longev 2022:7619255","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"5505_CR63","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng1001-166","volume":"29","author":"S Hadano","year":"2001","unstructured":"Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS et al (2001) A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 29(2):166\u2013173","journal-title":"Nat Genet"},{"key":"5505_CR64","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1038\/s41467-022-32619-z","volume":"13","author":"L Pihlstrom","year":"2022","unstructured":"Pihlstrom L, Shireby G, Geut H, Henriksen SP, Rozemuller AJM, Tunold JA (2022) Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathology. Nat Commun 13:4932","journal-title":"Nat Commun"},{"issue":"4","key":"5505_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043200","volume":"24","author":"F Bruno","year":"2023","unstructured":"Bruno F, Abondio P, Montesanto A, Luiselli D, Bruni AC, Maletta R (2023) The nerve growth factor receptor (NGFR\/p75NTR): a major player in Alzheimer\u2019s disease. Int J Mol Sci 24(4):3200","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5505_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41536-023-00311-5","volume":"8","author":"T Siddiqui","year":"2023","unstructured":"Siddiqui T, Cosacak MI, Popova S, Bhattarai P, Yilmaz E, Lee AJ et al (2023) Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2\/Slc22a17 signaling in Alzheimer\u2019s disease. NPJ Regen Med 8(1):33","journal-title":"NPJ Regen Med"},{"issue":"19","key":"5505_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914910","volume":"24","author":"ID Momin","year":"2023","unstructured":"Momin ID, Rigler J, Chitrala KN (2023) Analysis of potential biomarkers in frontal temporal dementia: a bioinformatics approach. Int J Mol Sci 24(19):14910","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5505_CR68","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1471-4159.2006.03921.x","volume":"98","author":"J Lewerenz","year":"2006","unstructured":"Lewerenz J, Klein M, Methner A (2006) Cooperative action of glutamate transporters and cystine\/glutamate antiporter system Xc\u2013protects from oxidative glutamate toxicity. J Neurochem 98(3):916\u2013925","journal-title":"J Neurochem"},{"key":"5505_CR69","doi-asserted-by":"crossref","unstructured":"Olsson MG, Rosenl\u00f6f LW, Kotarsky H, Olofsson T, Leanderson T, M\u00f6rgelin M, ... \u00c5kerstr\u00f6m B (2013) The radical-binding lipocalin A1M binds to a complex I subunit and protects mitochondrial structure and function. Antioxid Redox Signal 18(16):2017\u20132028","DOI":"10.1089\/ars.2012.4658"},{"key":"5505_CR70","doi-asserted-by":"crossref","unstructured":"Li C, Brazill JM, Liu S, Bello C, Zhu Y, Morimoto M, ..., Zhai RG (2017) Spermine synthase deficiency causes lysosomal dysfunction and oxidative stress in models of Snyder-Robinson syndrome. Nat Commun 8(1):1257","DOI":"10.1038\/s41467-017-01289-7"},{"key":"5505_CR71","doi-asserted-by":"crossref","unstructured":"Vaudry D, Pamantung TF, Basille M, Rousselle C, Fournier A, Vaudry H, ... Gonzalez BJ (2002) PACAP protects cerebellar granule neurons against oxidative stress\u2010induced apoptosis. Eur J Neurosci 15(9):1451\u20131460","DOI":"10.1046\/j.1460-9568.2002.01981.x"},{"issue":"20","key":"5505_CR72","doi-asserted-by":"publisher","first-page":"15466","DOI":"10.1074\/jbc.M000361200","volume":"275","author":"T Nguyen","year":"2000","unstructured":"Nguyen T, Huang HC, Pickett CB (2000) Transcriptional regulation of the antioxidant response element: activation by Nrf2 and repression by MafK. J Biol Chem 275(20):15466\u201315473","journal-title":"J Biol Chem"},{"issue":"12","key":"5505_CR73","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1016\/j.cellsig.2013.08.007","volume":"25","author":"M Buelna-Chontal","year":"2013","unstructured":"Buelna-Chontal M, Zazueta C (2013) Redox activation of Nrf2 & NF-\u03baB: a double end sword? Cell Signal 25(12):2548\u20132557","journal-title":"Cell Signal"},{"key":"5505_CR74","doi-asserted-by":"crossref","unstructured":"Hong DG, Song GY, Eom CB, Ahn JH, Kim SM, Shim A, ..., Yang YM (2022) Loss of ERdj5 exacerbates oxidative stress in mice with alcoholic liver disease via suppressing Nrf2. Free Radic Biol Med 184:42\u201352","DOI":"10.1016\/j.freeradbiomed.2022.03.027"},{"key":"5505_CR75","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00702-013-1157-z","volume":"121","author":"LC Lee","year":"2014","unstructured":"Lee LC, Weng YT, Wu YR, Soong BW, Tseng YC, Chen CM, Lee-Chen GJ (2014) Downregulation of proteins involved in the endoplasmic reticulum stress response and Nrf2-ARE signaling in lymphoblastoid cells of spinocerebellar ataxia type 17. J Neural Transm 121:601\u2013610","journal-title":"J Neural Transm"},{"issue":"1","key":"5505_CR76","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12017-024-08822-0","volume":"27","author":"C Huang","year":"2025","unstructured":"Huang C, Liu Y, Wang S, Xia J, Hu D, Xu R (2025) From genes to metabolites: HSP90B1\u2019s role in Alzheimer\u2019s disease and potential for therapeutic intervention. Neuromolecular Med 27(1):6","journal-title":"Neuromolecular Med"},{"key":"5505_CR77","doi-asserted-by":"publisher","first-page":"e98649","DOI":"10.7554\/eLife.98649","volume":"13","author":"Y Date","year":"2024","unstructured":"Date Y, Sasazawa Y, Kitagawa M, Gejima K, Suzuki A, Saya H, Kida Y, Imoto M (2024) Novel autophagy inducers by accelerating lysosomal clustering against Parkinson\u2019s disease. Elife 13:e98649","journal-title":"Elife"},{"key":"5505_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00376","volume":"12","author":"CI Tasca","year":"2018","unstructured":"Tasca CI, Lanznaster D, Oliveira KA, Fern\u00e1ndez-Due\u00f1as V, Ciruela F (2018) Neuromodulatory effects of guanine-based purines in health and disease. Front Cell Neurosci 12:376","journal-title":"Front Cell Neurosci"},{"key":"5505_CR79","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","volume":"20","author":"N Vijaratnam","year":"2021","unstructured":"Vijaratnam N, Simuni T, Brandmann O, Morris HR, Foltynie T (2021) Progress towards therapies for disease modification in Parkinson\u2019s disease. Lancet 20:559\u2013572","journal-title":"Lancet"},{"key":"5505_CR80","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373:2055\u20132066","journal-title":"Lancet"},{"key":"5505_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202000174","volume":"21","author":"J Tueshaus","year":"2020","unstructured":"Tueshaus J, Kataka ES, Zaucha J, Frishman D, Mueller SA, Lichtenhaler SF (2020) Neuronal differentiation of LUHMES cells induces substantial changes of the proteome. Proteomics 21:2000174","journal-title":"Proteomics"},{"key":"5505_CR82","doi-asserted-by":"publisher","first-page":"105608","DOI":"10.1016\/j.neuint.2023.105608","volume":"170","author":"N Ali","year":"2023","unstructured":"Ali N, Sane MS, Tang H, Compher J, McLaughlin Q, Jones CD, Maffi SK (2023) 6-hydroxydopamine affects multiple pathways to induce cytotoxicity in differentiated LUHMES dopaminergic neurons. Neurochem Int 170:105608","journal-title":"Neurochem Int"},{"key":"5505_CR83","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s43587-023-00478-y","volume":"3","author":"JB Pereira","year":"2023","unstructured":"Pereira JB, Kumar A, Hall S, Palmqvist S, Stomrud E, Bali D, Parchi P, Mattsson-Carlgren N et al (2023) DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. Nat Aging 3:1201\u20131209","journal-title":"Nat Aging"},{"key":"5505_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56293-z","volume":"16","author":"K Bolsewig","year":"2025","unstructured":"Bolsewig K, Willemse EAJ, Sanchez-juan P, Rabano A, Martinez M, Doecke JD, Bellomo G, Vermunt L et al (2025) Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment. Nat Commun 16:1139","journal-title":"Nat Commun"},{"issue":"4","key":"5505_CR85","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/j.1471-4159.2006.04146.x","volume":"99","author":"R Tehranian","year":"2006","unstructured":"Tehranian R, Montoya SE, Van Laar AD, Hastings TG, Perez RG (2006) Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells. J Neurochem 99(4):1188\u20131196. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04146.x","journal-title":"J Neurochem"},{"key":"5505_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031812","volume":"23","author":"L Seebauer","year":"2022","unstructured":"Seebauer L, Schneider Y, Drobny A, Ploetz S, Koudelka T, Tholey A, Prots I, Winner B et al (2022) Interaction of alpha synuclein and microtubule organization is linked to impaired neuritic integrity in Parkinson\u2019s patient-derived neuronal cells. Int J Mol Sci 23:1812","journal-title":"Int J Mol Sci"},{"key":"5505_CR87","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.bbrc.2011.12.092","volume":"417","author":"K Nakayama","year":"2012","unstructured":"Nakayama K, Suzuki Y, Yazawa I (2012) Binding of neuronal a-synuclein to bIII-tubulin and accumulation in a model of multiple systems atrophy. Biochem Biophys Res Commun 417:1170\u20131175","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"5505_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1523\/ENEURO.0327-21.2022","volume":"9","author":"RT Clements","year":"2022","unstructured":"Clements RT, Fuller LE, Kraemer KR, Radomski SA, Hunter-Chang S, Hall WC, Kalantar AA, Kraemer BR (2022) Quantification of neurite degeneration with enhanced accuracy and efficiency in an in vitro model of Parkinson\u2019s disease. eNeuro 9(2):1\u201318","journal-title":"eNeuro"},{"issue":"10","key":"5505_CR89","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1172\/JCI129987","volume":"129","author":"R Cai","year":"2019","unstructured":"Cai R, Zhang Y, Simmering JE, Schultz JL, Li Y, Fernandez-Carasa I, Consiglio A, Raya A et al (2019) Enhancing glycolysis attenuates Parkinson\u2019s disease progression in models and clinical databases. J Clin Invest 129(10):4539\u20134549","journal-title":"J Clin Invest"},{"key":"5505_CR90","doi-asserted-by":"publisher","first-page":"106696","DOI":"10.1016\/j.ejps.2024.106696","volume":"194","author":"Z Pan","year":"2024","unstructured":"Pan Z, Shao M, Zhao C, Yang X, Li H, Cui G, Ling X, Yu CW et al (2024) J24335 exerts neuroprotective effects against 6-hydroxydopamine-induced lesions in PC12 cells and mice. Eur J Pharm Sci 194:106696","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"5505_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030098","volume":"3","author":"TG Lesnick","year":"2007","unstructured":"Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, De Andrade M, Henley JR, Rocca WA et al (2007) A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 3(6):e98. https:\/\/doi.org\/10.1371\/journal.pgen.0030098","journal-title":"PLoS Genet"},{"issue":"7425","key":"5505_CR92","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11557","volume":"491","author":"GH Liu","year":"2012","unstructured":"Liu GH, Qu J, Suzuki K, Nivet E, Li M, Montserrat N, Yi F, Xu X et al (2012) Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature 491(7425):603\u2013607","journal-title":"Nature"},{"key":"5505_CR93","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1093\/hmg\/11.20.2395","volume":"11","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Brundin P (2002) Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson\u2019s disease. Hum Mol Genet 11:2395\u20132407","journal-title":"Hum Mol Genet"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05505-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:12:10Z","timestamp":1765966330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05505-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5505"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05505-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"304"}}